Maria Choy, MD

05/25/2026

This 2025 article describes four diabetic patients who showed improved HbA1c levels and cholesterol levels while taking daily ivermectin for months to two years. Patient examples include drops from around 9-10% to 5.6-7.6%, with some also seeing better liver markers. The authors note these are only anecdotes. Based on existing lab and animal research, ivermectin may be acting on the FXR receptor to affect glucose and lipid metabolism, plus possible effects on insulin secretion in beta cells.

They find weak supportive signals for temporality and dose response but stress the need for proper clinical trials. Unfortunately, I am not aware of any ongoing trials for this.

05/18/2026

This 2025 State‑of‑the‑art review synthesizes recent primary studies, explains EMI mechanisms, and evaluates regulatory guidance for electronic vehicles. It concludes current studies show no clear risk from EV chargers to pacemakers/ICDs, but research is limited — more standardized testing and ongoing monitoring needed." As charging fields expand (eg highway that charges your car while driving), this risk might increase. My advise to cardiac patients is to err on the side of caution right now when it comes to highway and fast chargers. Perhaps, cardiac electronic devices need to do research to keep up with the times: perhaps an EMF blocker around their devices?

05/06/2026

More evidence that out gut bacteria determines our health: f***l transplants can improve Parkinson’s

F***l microbiota transplantation is linked to improvements in both motor and non-motor outcomes in Parkinson’s disease, at least in the short term, a new meta-analysis shows.

05/05/2026

Releasing painful memories both physically and verbally results in relief in 70%. Here is how you can try it:

https://m.facebook.com/story.php?story_fbid=1503442147894145&id=100046851231270

1. The ritual was called “Wičháŋpi Wóyute” — star feeding.
Lakota healers used it for those who lost loved ones or survived violence.
The person didn’t talk about the trauma.

They fed it.

They’d gather stones representing the pain, then carry them to a river and release them one by one while speaking the memory out loud to the water.

The final stone was kept as a reminder that grief was witnessed, not erased.
🪨🌊

2. The practice was banned by missionaries in the 1800s as “primitive superstition.”
But in 2019, Johns Hopkins trauma researchers recreated it with PTSD patients.

They found the physical act of releasing objects while verbalizing trauma engages both hemispheres of the brain — something talk therapy alone doesn’t achieve.

Results after 6 sessions:
• PTSD symptom reduction: 73%
• Intrusive thoughts decreased by 81%
• Emotional regulation improved 6x faster than traditional therapy
🧠

3. The protocol (modern adaptation):
• Gather small objects (stones, paper, anything tangible)
• Each object represents one painful memory or feeling
• Go to a natural setting (river, ocean, forest)
• Hold each object, speak the memory out loud
• Release it physically (throw it, bury it, burn it)
• Keep one object as a witness
The act of physical release signals to the brain that the memory has been processed.
🔥

4. Therapy organizations pushed back hard.

One psychologist association called it:
“Unscientific and potentially harmful.”
But the data showed otherwise.

The modern therapy model profits from long-term treatment.

A ritual that works in 6 sessions disrupts a multi-billion-dollar industry.
💰

5. Try it with one painful memory.
Lakota healers said:
“The wound that’s held grows.
The wound that’s released heals.”

Your brain doesn’t need endless analysis.

It needs a signal that the pain has been acknowledged and can be released.
Most people are still carrying stones from decades ago.

04/17/2026

The Soul of Healing: Discovering the Science of God's Design for Lasting Health ©
My book is at Editor's Desk!

04/15/2026

This is a systematic review and meta-analysis of 69 prospective cohort studies involving millions of community-dwelling adults aged 35 and older. The analysis examined associations between physical activity, sedentary behavior, sleep duration, and later dementia risk. They found that dementia risk is 25% less likely with simple life style habits that we can all implement:

1. Regular physical activity was associated with an average ~25% lower risk of dementia.

2. Sedentary behavior (e.g., sitting more than 8 hours/day) was linked to higher risk (around 27–30% increase in some analyses).

3. Sleep duration showed a U-shaped relationship: both too little (8 hours) were associated with increased risk, while 7–8 hours appeared optimal.

4. Breaking up prolonged sitting and combining activity with appropriate sleep had notable protective associations

See you all at the park!!!

CRD42021272054.

04/13/2026

A Swedish study followed over 27,000 people for 25 years and found that people who ate more high-fat cheese (like cheddar, brie, or gouda — about 2 ounces a day) had around 13% lower risk of dementia later on. Same with people having a bit of high-fat cream. My patients hear this from me a lot: we need healthy fats to make the lipid by-layer that surrounds each cell. If you have saturated fats, the cells have a double bonded wall. If you had poly-unsaturated fats, portions or the wall are single bonded and will not be as strong. We cannot ignore basic physiology when choosing our foods. Coconut oil is a medium chain saturated fat (as compared to long chained animal saturated fat). It is easier to break down to incorporate into cells.

Of course, it goes without saying that you need to follow your blood tests since genetics determines what is able to be used. Swedish people evolved in dairy society. Their body's management of fat would be quite different from society not based on dairy (like Asians)

Background and ObjectivesThe association between dairy intake and dementia risk remains uncertain, especially for dairy products with varying fat contents. The aim of this study was to investigate the association between high-fat and low-fat dairy intake ...

03/27/2026

Some of you know I ride horses. It is one of my “add-on” skills to stay mentally and physically sound. Core muscles are triggered just by sitting balanced on a horse. My reaction time is kept sharp … to prevent unplanned ground contact. My timing is improved as I go over a fence. Lastly, there is nothing better than being in touch with nature. Keeping the body sound, keeps the mind sound.

03/27/2026

Cautiously exploring: Keppra may help cognitive function in Alzheimer's Disease

What is Keppra?

Keppra (levetiracetam) is a medication that has been used for many years to prevent seizures. Recently, researchers have been studying whether it might also help people with Alzheimer's disease.

How might Keppra help in Alzheimer's disease?

Scientists have discovered that Keppra may work in two ways for Alzheimer's disease:

First, it may reduce the buildup of harmful proteins called amyloid plaques in the brain. These plaques are one of the hallmarks of Alzheimer's disease. In laboratory studies with mice, Keppra changed how brain cells process proteins, leading to less plaque formation. However, this has not yet been proven in human studies.

Second, Keppra may help with abnormal electrical activity in the brain. Some people with Alzheimer's have unusual brain wave patterns (even without having visible seizures) that can worsen memory and thinking. A clinical trial found that low-dose Keppra improved memory and thinking skills in Alzheimer's patients who had these abnormal brain wave patterns.

Is this a proven treatment?

Keppra is not currently approved by the FDA for treating Alzheimer's disease. The research is still in early stages. While the medication showed promise in some patients, particularly those with abnormal brain electrical activity, more studies are needed to understand if it can slow down Alzheimer's disease or reduce brain plaques in people.


1. . Levetiracetam Prevents Aβ Production Through SV2a-dependent Modulation of APP Processing in Alzheimer's Disease Models. Rao NR, Santiago-Marrero I, DeGulis O, et al. Science Translational Medicine. 2026;18(836):eadp3984. doi:10.1126/scitranslmed.adp3984.

2. Levetiracetam Treatment Normalizes Levels of Presynaptic Endocytosis Machinery and Restores Nonamyloidogenic APP Processing in Knock-in Mice. Rao NR, Savas JN. Journal of Proteome Research. 2021;20(7):3580-3589. doi:10.1021/acs.jproteome.1c00180.

3. Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial. Vossel K, Ranasinghe KG, Beagle AJ, et al. JAMA Neurology. 2021;78(11):1345-1354. doi:10.1001/jamaneurol.2021.3310.

03/17/2026

All vaccines are not created equal. The original handful of childhood vaccines have good data to support its use. The same cannot be said of newer vaccines such as Gardasil or vaccines for rapidly mutating viruses. However, I cannot stay silent when half truths are being circulated such as blaming measles outbreak on current attempts to change vaccine mandates. I doubt that MMR vaccine will be affected by policies that are being discussed. THE DROP IN MMR VACCINATION occurred DURING AND BECAUSE OF covid mandates and many are still not caught up (see below, this is from AI for health professionals literature search). The measles outbreak has little to do with current administration and much to do with Covid isolation policies as has much or our medical preventative managements.